AccuStem Sciences Limited
ACMSY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,505 | – | -$3,746 | – |
| Dep. & Amort. | $4 | – | $3 | – |
| Deferred Tax | $0 | – | $0 | – |
| Stock-Based Comp. | $70 | – | $134 | – |
| Change in WC | $0 | – | -$1,806 | – |
| Other Non-Cash | $768 | – | $3,609 | – |
| Operating Cash Flow | -$664 | – | -$1,806 | – |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | – | $0 | – |
| Net Acquisitions | $0 | – | $0 | – |
| Inv. Purchases | $0 | – | $0 | – |
| Inv. Sales/Matur. | $0 | – | $0 | – |
| Other Inv. Act. | $0 | – | -$11 | – |
| Investing Cash Flow | $0 | – | -$11 | – |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | – | $0 | – |
| Stock Issued | $0 | – | $2,676 | – |
| Stock Repurch. | $0 | – | $0 | – |
| Dividends Paid | $0 | – | $0 | – |
| Other Fin. Act. | $648 | – | $2,551 | – |
| Financing Cash Flow | $648 | – | $2,551 | – |
| Forex Effect | $0 | – | $0 | – |
| Net Chg. in Cash | -$16 | – | $734 | – |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $21 | – | $0 | – |
| End Cash | $5 | – | $734 | – |
| Free Cash Flow | -$664 | – | -$1,806 | – |